Skip to main content
SRZN logo

SRZN · Surrozen, Inc. · Metrics

Track SRZN — free
$30.67 -1.07 (-3.37%) At close · Nov 19 Q4 2022 earnings call transcript
Market Cap
$584.62M
Shares
19.06M
Volume · Nov 19 91.68K Avg daily vol (3M) 531.11K

SRZN metrics

65 of 125 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$30.67
Market cap
$584.62M

Price action

23 metrics
Price change (1W)
-3.2%
Price change (30D)
+21.1%
Price change (3M)
+30.5%
Price change (6M)
+13.2%
Price change (YTD)
+35.7%
Price change (1Y)
+127.2%
Trailing year
Price change (5Y)
—
52-week high
$34.13
52-week low
$13.10
Change from 52-week high
-10.1%
Change from 52-week low
+134.1%
Annualized volatility
135.8%
Annualized volatility (3M)
229.8%
Implied volatility (30D)
197.7%
IV rank (1Y)
—
IV percentile (1Y)
—
Beta
1.6
RSI (14D)
53.9
Price vs SMA 50
+14.7%
Price vs SMA 200
+18.9%
Avg volume (3M)
531,114
Relative volume
0.2
Average dollar volume
$15.44M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
19.06M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
55.5×
reciprocal yield 1.8%
P / book
—
FCF yield
-5.3%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-66.7%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2023-03-22

Profitability

9 metrics
Gross margin
—
Operating margin
-485.4%
Trailing 12 months
Net margin
-3,706.4%
Gross profit (TTM)
—
Operating profit (TTM)
−$51.11M
Net income (TTM)
−$390.21M
Trailing 12 months
Diluted EPS (TTM)
$-42.21
FCF margin
-292.3%
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$-19.21

Growth

11 metrics
Revenue growth YoY
-100.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$10.53M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+37.4%
Year over year · more shares
Revenue CAGR (3Y)
-34.7%
Revenue CAGR (5Y)
—
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
-357.9%
Debt / equity
—
Current ratio
7.6
EBITDA (TTM)
−$50.90M
Free cash flow (TTM)
−$30.77M
Quick ratio
7.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
$100.35M
Latest balance sheet
Cash & equivalents
$100.35M
Total assets
$109.03M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$30.55M
Capital expenditures (TTM)
$225,000
R&D (TTM)
$37.64M
SG&A (TTM)
—
Stock compensation (TTM)
$8.93M
R&D / revenue
357.5%
Stock compensation / revenue
84.8%

Ownership (13F)

9 metrics
13F filers
94
13F filer change QoQ
+24
Institutional ownership
82.3%
Conviction holders (share of 13F filers)
7.4%
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
+24.0%
Holder tenure
7.6
Price vs estimated holder cost
+25.4%

Ownership (registered funds)

1 metrics
Index-fund ownership
3.9%

Short interest

3 metrics
Short interest
17.0%
Latest settlement · 8.5 days to cover
Days to cover
8.5d
Short-squeeze score
74 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1824893 CUSIP 86889P208 13F (30d) 98 filings 94 filers Visit website Investor relations